EPISODE · Oct 24, 2019 · 28 MIN
Episode 85: Every angle on Biogen's shocking Alzheimer's news
from The Readout Loud · host STAT
What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We're devoting this entire episode to Biogen's stunning announcement that aducanumab, its once-discarded treatment for Alzheimer's disease, is getting a second life.
Embed this episode
NOW PLAYING
Episode 85: Every angle on Biogen's shocking Alzheimer's news
0:00
28:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Readout Loud?
This episode is 28 minutes long.
When was this The Readout Loud episode published?
This episode was published on October 24, 2019.
Can I download this The Readout Loud episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!